The transatlantic row over algorithmic favouritism for British broadcasters previews a fight already brewing inside the NHS over who gets to be believed online.
A London trial for a rare blood cancer drug tests more than a molecule; it tests whether Britain's research ambitions can survive its NHS operating conditions
The former AstraZeneca executive brings two decades of clinical leadership to direct regulatory strategy for the firm's chronic disease therapies
A nationwide move to streamline utility procurement aims to cut costs and improve operational efficiency across the health service
A new unified dispatch and records system signals a nationwide shift toward AI and automation across regional emergency responders
A small Sussex manufacturer's export slowdown exposes the gap between Whitehall's life sciences ambitions and the commercial reality facing the firms it depends on
A £200,000 asset freeze under the Proceeds of Crime Act exposes how far demand for weight-loss drugs has outrun the system meant to supply them safely
Why haematology needs to measure what treatment asks of patients over time
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
